Optometrists in Methuen, MA Accepting Medicare

7 Optometrists found. Showing 1 - 7

Advanced Family Eyecare Limited Optometrist Medicare: Medicare Enrolled Practice Location: 50 Haverhill St, Methuen, MA 01844 Phone: 978-682-5656    Fax: 978-685-7959

Janette L. Liu, Od And Associates, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 90 Pleasant Valley St, Suite 250, Methuen, MA 01844 Phone: 978-683-2020    Fax: 978-683-2040

Dr. Stephen Joseph Angelo, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 154 Haverhill St, Methuen, MA 01844 Phone: 978-794-9500    Fax: 978-794-9504

David Kahan, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 436 Broadway, Methuen, MA 01844 Phone: 978-687-3220    Fax: 978-794-1457

Kevin M. Gasiorowski, Od Optometrist Medicare: Not Enrolled in Medicare Practice Location: 188 Broadway, Methuen, MA 01844 Phone: 978-794-1445    Fax: 978-975-5430

David I Kahan Od Pc Optometrist Medicare: Medicare Enrolled Practice Location: 436 Broadway, Methuen, MA 01844 Phone: 978-687-3220

Mr. James Doyle, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 50 Haverhill St, Methuen, MA 01844 Phone: 978-682-5656    Fax: 978-685-7959

News Archive

New Image to build dairy plant in New Zealand

Health and wellness products manufacturer New Image Group is to help meet global demand for more nutritional milk products with the building of a multi-million dollar, spray drying plant in New Zealand.

Researchers to study how dust particles pose health threat to people

Residents of the southern United States and the Caribbean have seen it many times during the summer months-a whitish haze in the sky that seems to hang around for days. The resulting thin film of dust on their homes and cars actually is soil from the deserts of Africa, blown across the Atlantic Ocean.

Regence takes action to prevent gap in health care coverage

Regence, the largest insurer in the Northwest/Intermountain Region, announced today that it is taking action to prevent a gap in coverage that could leave many young members uninsured.

OncoMed commences dosing in OMP-54F28 Phase I clinical trial for advanced solid tumor cancers

OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel therapeutics that target cancer stem cells, or tumor-initiating cells, today announced that patient dosing has begun in a Phase I clinical trial of OMP-54F28 in patients with advanced solid tumor cancers.

Extracts from algae, rosemary and monk fruit could soon replace synthetic ingredients and food additives

Extracts from algae, rosemary and monk fruit could soon replace synthetic ingredients and food additives such as Blue No. 1, BHT and aspartame that label-conscious grocery shoppers are increasingly shunning.

Read more Medical News

› Verified 9 days ago